Schroder Investment Management Group
KERX

Schroder Investment Management Group’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Schroder Investment Management Group’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-41,191
Closed -$634K – 1518
2014
Q2 		$634K Hold
41,191
– – ﹤0.01% 1033
2014
Q1 		$702K Buy
+41,191
New +$621K ﹤0.01% 1011

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Schroder Investment Management Group's KERX Position: Q3 2014 in Review

Schroder Investment Management Group sold out of Keryx Biopharmaceuticals Inc (KERX) in Q3 2014, closing a stake of 41,191 shares — an estimated $634K sold.

Schroder Investment Management Group first reported a position in KERX in Q1 2014 and held it in 2 quarters. The position peaked at $702K in Q1 2014. 140 funds tracked by Wall St. Rank hold KERX as of Q3 2014.

  • Schroder Investment Management Group reported no remaining Keryx Biopharmaceuticals Inc position as of Q3 2014 after selling out during the quarter.
  • Schroder Investment Management Group sold 41,191 Keryx Biopharmaceuticals Inc shares in Q3 2014, an estimated $634K.
  • Schroder Investment Management Group first reported a position in Keryx Biopharmaceuticals Inc in Q1 2014 and held it in 2 quarters.
  • Schroder Investment Management Group's Keryx Biopharmaceuticals Inc position peaked at $702K in Q1 2014.
  • 140 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q3 2014.

Based on Schroder Investment Management Group's 13F filing for Q3 2014, filed 13 Nov 2014.